poisar

Stocks · News reference

8-K filing — KOHLS Corp (KSS)

SEC EDGARAug 26, 2026, 11:00 AMSEC EDGAR

Filed: 2026-08-26 AccNo: 0001193125-26-365860 Size: 8 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Aug 26, 2026, 11:00 AM
Checked
Aug 26, 2026, 11:00 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchAug 27, 2026, 4:09 PMNa

    Kohl's Q2 Earnings Beat Shifts Focus to Holiday Execution and Margins

    Kohl's reported adjusted Q2 EPS of $1.28, up 128.6% year-over-year, beating expectations despite a 0.9% revenue decline. The company raised full-year adjusted EPS guidance to $1.80-$2.40 and improved its sales outlook. However, margin expansion was significantly aided by $100M in tariff refunds, and the company faces execution challenges in the critical holiday season ahead.

    Read original at zacks-investment-research
  2. Zacks Investment ResearchAug 27, 2026, 4:04 PMNa

    Is Kohl's Stock a Buy as Value Meets a Still-Fragile Sales Recovery?

    Kohl's (KSS) trades at a discount to market benchmarks with improved earnings guidance raised to $1.80-$2.40 per share and strengthened liquidity ($821M cash). However, negative comparable sales trends and recent downward earnings estimate revisions temper the recovery outlook. The stock carries a Zacks Rank #1 with a Value Score of A but Momentum Score of C, suggesting measured optimism rather than confirmed recovery.

    Read original at zacks-investment-research
  3. Zacks Investment ResearchAug 27, 2026, 4:02 PMNa

    Kohl's Stock Is Up 15.6% in 3 Months: Is the Rebound Sustainable?

    Kohl's shares gained 15.6% over three months following a strong Q2 earnings beat with adjusted EPS of $1.28 versus consensus of $0.55. The company showed improved merchandising, expanded gross margins, and strengthened liquidity. However, comparable sales remain negative and full-year guidance calls for flat to down 1.5% sales, leaving the top-line recovery unproven. The stock trades above its five-year valuation median, raising questions about sustainability.

    Read original at zacks-investment-research